Pharmas Say EU Nations Seize Indian Drugs Bound For Latin America
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are looking to bypass European ports when they ship their products to Latin American countries. The Pharmaceuticals Export Promotion Council in India said several drug makers have complained about their shipments being seized in some EU countries as their products pass through on their way to Latin America. Customs agents in France, Germany, The Netherlands and the United Kingdom have seized recent shipments based on the EU's new definition of counterfeit drugs and patent infringement. The drugs are legal in their destination country, the drug makers argue, and should be allowed to pass through Europe. (Click here for more
You may also be interested in...
India Opposes Seizure Of Drugs By EU Even As Dr. Reddy’s Labs Brings Its Goods Back
MUMBAI - Stung by strictures on Indian companies routing drug consignments through the European Union, the Indian government is considering drastic measures in a bid to control further damage to India's pharmaceutical trade
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.